Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age- Related Macular Degeneration

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 90-95

Bentham Science Publishers

Access to resources Recommend Favorite

Orientation and mobility in age-related macular degeneration

By Hassan S.E.   Lovie-Kitchin J.E.   Woods R.L.   Soong G.P.-Y.  

Visual Impairment Research, Vol. 1, Iss. 3, 1999-12 ,pp. : 175-180

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor: Current Status and Future Challenges in Cancer Therapy

By Hsu Jerry Y.   Wakelee Heather A.  

BioDrugs, Vol. 23, Iss. 5, 2009-10 ,pp. : 289-304

Adis International

Access to resources Recommend Favorite

Neovascular Age-Related Macular Degeneration: Opportunities for Development of First-in-Class Biopharmaceuticals

By Schiffelers Raymond M.   >   Storm Gert  

BioDrugs, Vol. 25, Iss. 3, 2011-06 ,pp. : 171-189

Adis International

Access to resources Recommend Favorite

New Pharmacologic Approaches to Therapy for Age-Related Macular Degeneration

By Eter Nicole   Krohne Tim U.   Holz Frank G.  

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 167-179

Adis International

Access to resources Recommend Favorite